Prolapsed Submucous Myoma Mimicking Cervical Carcinoma
The critical first step is obtaining tissue diagnosis through cervical biopsy to definitively exclude cervical carcinoma, followed by pelvic MRI to characterize the lesion and guide surgical planning.
Diagnostic Work-Up
Initial Clinical Assessment
When a prolapsed submucous myoma presents at the cervix or vagina, it can closely mimic cervical carcinoma clinically, presenting with abnormal vaginal bleeding, offensive discharge, and a visible cervical mass 1. The key distinguishing features to identify on examination include:
- Palpation of a stalk connecting the mass to the uterine fundus
- Smooth, firm consistency rather than friable tissue
- Cervical os displacement rather than cervical involvement
- Absence of cervical ulceration or induration
Essential Diagnostic Studies
Cervical biopsy is mandatory to exclude malignancy before proceeding with any surgical intervention 2. This cannot be skipped even when clinical suspicion for myoma is high, as misdiagnosis of cervical cancer has been documented 1.
MRI pelvis is the gold standard imaging modality for characterizing prolapsed submucous myomas 3, 4. MRI provides critical information for surgical planning:
- Confirms the diagnosis and presence of a stalk
- Defines the caudal extent of prolapse
- Identifies hemorrhage or degeneration
- Maps the relationship to vital pelvic structures
- Distinguishes from cervical carcinoma or sarcoma 5
MRI correctly identified prolapsed myomas and their characteristics prospectively in all cases in published series, with the ability to localize the stalk aiding subsequent hysteroscopic resection 4.
Ultrasound with saline infusion sonohysterography can be used as an alternative or adjunct, particularly for assessing the intracavitary component, though MRI provides superior anatomic detail for surgical planning 5.
Common Diagnostic Pitfalls
The most serious pitfall is misdiagnosing advanced cervical cancer as a prolapsed myoma, which has led to delayed cancer treatment 1. Conversely, treating a prolapsed myoma as cervical cancer can result in inappropriate radical surgery. Always obtain tissue diagnosis before definitive treatment 2.
Management Approach
Immediate Considerations
Assess for complications requiring urgent intervention:
- Severe hemorrhage (may require clamping of the stalk or emergency surgery)
- Infection/sepsis (requires antibiotics and expedited removal)
- Necrosis with gangrenous changes 6
- Severe anemia requiring transfusion 1
Definitive Surgical Management
For patients desiring fertility preservation, the preferred approach is combined vaginal and hysteroscopic myomectomy 7. This technique involves:
- Adequate vaginal exposure of the prolapsed portion
- Clamping the myoma stalk to control bleeding
- Morcellation using a "cone" technique to debulk the vaginal component
- Intracervical vasopressin injection (consider for hemostasis)
- Hysteroscopic evaluation and completion of stalk resection
- Intrauterine balloon placement for hemostasis
This minimally invasive approach has low complication rates (5.6% in systematic review) and preserves fertility 8.
For patients not desiring fertility, total hysterectomy is the definitive treatment with the highest satisfaction rates (>90%) and eliminates recurrence risk 9, 10. This is particularly appropriate when:
- The myoma is extremely large (>10 cm)
- Multiple myomas are present
- The patient has completed childbearing
- Severe necrosis or infection is present 6
Alternative Approaches
Myomectomy via laparoscopy or laparotomy may be required for:
- Large cervical myomas with significant supravaginal extension
- Inability to access the stalk vaginally
- Multiple myomas requiring removal 8
Uterine artery embolization has high failure rates (up to 23% at 10 years) specifically for cervical fibroids and is not recommended as primary treatment for prolapsed cervical myomas 9.
Critical Surgical Considerations
Cervical myomas pose unique surgical challenges due to proximity to ureters, bladder, and major vessels 8. Preoperative MRI mapping is essential to identify these relationships and plan the surgical approach safely.
Avoid morcellation if there is any concern for occult malignancy, as this can worsen outcomes in undiagnosed sarcoma 9.
Post-Operative Management
Following myomectomy, recurrence rates range from 23-33% 9, 10. Patients should be counseled about this risk and the potential need for future intervention. Close follow-up with pelvic examination and imaging is warranted, particularly in younger patients who have higher recurrence rates.
For patients who underwent fertility-sparing surgery, pregnancy should be delayed until adequate healing has occurred (typically 3-6 months), and cesarean delivery may be recommended depending on the extent of myometrial disruption.